Clinical Trials Logo

Chronic Renal Failure clinical trials

View clinical trials related to Chronic Renal Failure.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06046261 Completed - Clinical trials for Chronic Kidney Disease

Exploring the Impact of " ACP Board Game for Life" on Death Preparation and Anxiety in Patients With Stage 4 and 5 Chronic Kidney Diseases: A Pilot Study

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

This study was to explore the impacts of participating in "ACP board game for life" on death preparation, death anxiety, end-of-life care preferences, and intervention perception in stage 4-5 CKD patients with advanced chronic kidney diseases in a medical center.

NCT ID: NCT05699109 Completed - Clinical trials for Chronic Renal Failure

Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients

Start date: January 1, 2021
Phase:
Study type: Observational

This observational study aims to compare long-acting darbepoetin alpha versus short-acting epoetin alpha erythropoietin-stimulating agents in Egyptian hemodialysis patients. The main questions aim to answer are: - What are the effectiveness and safety of long- acting versus short-acting erythropoietin-stimulating agents in Egyptian hemodialysis patients? - What is the cost-effectiveness of long- acting versus short-acting erythropoietin-stimulating agents in Egyptian hemodialysis patients? Participants will be divided into 2 groups; epoetin alfa (short-acting ESA), Eprex group, and darbepoetin alfa (long-acting ESA), Aranesp group for six month study period.

NCT ID: NCT05631782 Completed - Hemodialysis Clinical Trials

Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients

Start date: November 10, 2020
Phase: Early Phase 1
Study type: Interventional

To explore the clinical effect of Shenkang Decoction in chronic renal failure (CRF) patients with hemodialysis (HD).

NCT ID: NCT05339997 Completed - Clinical trials for Chronic Kidney Diseases

Evaluation of Respiratory Function and Functional Capacity in Pediatric Patients With Chronic Kidney Disease (CKD)

Start date: February 15, 2022
Phase:
Study type: Observational

Chronic kidney disease (CKD) is defined as a permanent abnormality in kidney structure or function that persists for more than 3 months (for example, glomerular filtration rate [GFR] <60 mL/min/1.73 m2 or albuminuria ≥30 mg/24 hours) and, it effects the 8% to 16% of the population worldwide.In pediatric patients with CKD, exercise capacity begins to decline in stage 3 of the disease and progressively decreases in stage 5, in dialysis and transplant patients (4, 5). Reduction in respiratory muscle strength and six minute walk test (6MWT) is observed in patients with CKD treated with hemodialysis (HD).The aim in present study is to evaluate the relationship between functional capacity and respiratory functions in stage 1-5 pediatric chronic kidney disease patients.

NCT ID: NCT04952506 Completed - Clinical trials for Chronic Renal Failure

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

Start date: July 19, 2021
Phase: Phase 1
Study type: Interventional

This study is a randomized, open-label, single dosing, 3-treatment, 6-sequence, 3-period, crossover-design study to compare the pharmacokinetics and safety of D113 with CKD-349 in healthy volunteers.

NCT ID: NCT04700631 Completed - Clinical trials for Chronic Renal Failure

Extracellular Vesicles as Biomarkers for Chronic Renal Failure

VE-IRC
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The recent discovery of extracellular vesicles (EV) as a mechanism of intercellular communication has made it possible to develop a new field of health research and could bring new information on the pathological mechanisms of renal diseases. Definition of physiologic and pathologic values of urinary extracellular vesicles (EVu) between healthy subjects and chronic kidney diseases (CKD) patients could be a new tool for follow up of renal diseases. EV are found in all biological fluids including urine, that's why they are increasingly analyzed in renal pathologies. The main objective of this study is to determine the physiological values and the pathological thresholds of EVu.

NCT ID: NCT04697459 Completed - Clinical trials for Chronic Renal Failure

Chronic Intradialytic Exercise : a Cardioprotective Role

EX-CHRODIAL
Start date: December 13, 2020
Phase: N/A
Study type: Interventional

The main objective is to assess the effects of chronic intradialytic physical exercise on myocardial remodelling and regional function.

NCT ID: NCT04655989 Completed - Clinical trials for Chronic Renal Failure

A Study to Demonstrate the Safety and Effectiveness of the NIKKISO DBB-EXA ES Hemodialysis Delivery System

HEMO
Start date: November 30, 2020
Phase: N/A
Study type: Interventional

The study objective is to verify the safety and effectiveness of the DBB-EXA ES Hemodialysis Delivery System to consistently deliver dialysate of the appropriate quality for infusion.

NCT ID: NCT04536636 Completed - Clinical trials for Chronic Renal Failure

Docohexanoic Acid in Hemodialysis Patients

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Docohexanoic acid (DHA), a dietary n-3 polyunsaturated fatty-acid omega-3 (n-3, PUFA), showed potential beneficial effects in reducing all-cause mortality in hemodialysis (HD) patients. This clinical trial aimed to analyze whether DHA supplementation was a modulator of erythropoietin (EPO) response and inflammation in hemodialysis (HD) patients.

NCT ID: NCT04399655 Completed - Clinical trials for Renal Insufficiency, Chronic

Highlighting the Medico-economic Interest of an Adapted Physical Activity for Haemodialysis Patients

NEPHRACTIVE
Start date: November 12, 2020
Phase:
Study type: Observational

Chronic hemodialysis is often associated with a reduction in the quality of life of patients and a reduction in physical activity, due to the repeated frequency of sessions. Various studies conducted in hemodialysis patients have shown the beneficial effects of physical exercise during hemodialysis sessions on reducing cardiovascular risk, the number of hospitalizations and improving quality of life. It also contributes to improved patient adherence to care. Finally, it has been shown that exercise during the hemodialysis session is safe for the patient and does not disrupt dialysis parameters. Nevertheless, there are no data on the medico-economic impact of such a program. Based on the investigators' experience, the investigators have developed a specific protocol linking the different types of physical activity that have provided evidence of their efficiency and used in standard practice in the investigators' institutions. From tests and questionnaires assessing the physical abilities of patients have already validated for this population in this pathology. The objective of this project is to show the medico-economic interest of an adapted physical activity program for hemodialysis patients.